æ°ããªç 究ã«ãããCOVID-19ã¯ã¯ãã³ãšãããšã®é¢é£ã瀺ãç§åŠç蚌æ
æè¿ã®ããã€ãã®ç 究ã¯ãCOVID-19ã¯ã¯ãã³ãšçã®é¢é£æ§ã瀺ãç§åŠç蚌æ ãå¢ããç¶ããŠãããæåã®ç 究ã¯ãæ°ãã«çºè¡šããããã¬ããªã³ãã§ãSARS-CoV-2ãŠã€ã«ã¹ããã³mRNAã¯ã¯ãã³ã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªãè «çæå¶ãæ ãéèŠãªã¿ã³ãã¯è³ªãé»å®³ããçã®çºççãé«ããå¯èœæ§ãããããšã瀺ããŠããã
ãã®ç 究ã¯ãSARS-CoV-2ã¹ãã€ã¯S2ãµããŠããããç现èã«ãããp53ã«ããp21(WAF1)ãTRAILãã¹ã¬ã»ãã¿ãŒDR5ãããã³MDM2ã¿ã³ãã¯è³ªã®æŽ»æ§åãæå¶ããããšããã¿ã€ãã«ã§ããã©ãŠã³å€§åŠã®ç 究è ã«ãã£ãŠèãããã圌ãã¯ãã¯ã¯ãã³ããã³ãŠã€ã«ã¹ã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªã®S2æåããDNAæå·ã®å¿çããã³ä¿®åŸ©ã«ãããŠéèŠãªåœ¹å²ãæããè «çæå¶ã¿ã³ãã¯è³ªã§ããP53ãšçžäºäœçšãããã©ããã調æ»ããã
圌ãã¯ãS2æåãP53ãæå¶ããããšãçºèŠããããã¯ãSARS-CoV-2ææãè «ç圢æãè «çé²è¡ããããŠååŠçæ³æåæ§ã«åœ±é¿ãäžããå¯èœæ§ãããååæ©æ§ãæäŸããããšè¿°ã¹ãŠããã
ãã®ãã¬ããªã³ãã¯ãç 究è ãã¡ãCOVID-19ã¯ã¯ãã³ãSARS-CoV-2ãŠã€ã«ã¹ã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªããçïŒããïŒã®ãªã¹ã¯ãå¢å ãããå¯èœæ§ããããšããæžå¿µã瀺åããŠããŸãã以äžèŠçŽã§ãã
SARS-CoV-2ãŠã€ã«ã¹ã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªã®äžéšã§ããS2ãµããŠãããããè «çæå¶ã¿ã³ãã¯è³ªã§ããP53ã®æ©èœãæå¶ããå¯èœæ§ãããããšã瀺åããŠãããP53ã¯ãDNAæå·ã®ä¿®åŸ©ã现èåšæã®å¶åŸ¡ãè¡ãéèŠãªã¿ã³ãã¯è³ªã§ãããè «çã®çºçãé²ã圹å²ãæ ã£ãŠããã
2.ã¯ã¯ãã³ãšã®é¢é£æ§
ãã®ç 究ã¯äž»ã«ãŠã€ã«ã¹ã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªã«çŠç¹ãåœãŠãŠããããåãã¹ãã€ã¯ã¿ã³ãã¯è³ªãmRNAã¯ã¯ãã³ã«ãã£ãŠäœå ã§çæããããããmRNAã¯ã¯ãã³ãåæ§ã®åœ±é¿ãäžããå¯èœæ§ããããããã«ãããè «çã®åœ¢æãé²è¡ããããŠçæ²»çã«å¯Ÿããæåæ§ã«åœ±é¿ãäžããå¯èœæ§ããããšããŠããŸãã
3.å è¡ç 究ãšã®äžèŽ
å¥ã®ç 究ã§ã¯ãCOVID-19 mRNAã¯ã¯ãã³ã«äœ¿çšããã修食ãããRNAïŒN1-ã¡ãã«ã·ã¥ãŒããŠãªãžã³ïŒããçã®æé·ãä¿é²ããå¯èœæ§ããããšè¿°ã¹ãŠããã
æè¿ã®ããã€ãã®ç 究ã¯ãCOVID-19ã¯ã¯ãã³ãšçã®é¢é£æ§ã瀺ãç§åŠç蚌æ ãå¢ããç¶ããŠãããæåã®ç 究ã¯ãæ°ãã«çºè¡šããããã¬ããªã³ãã§ãSARS-CoV-2ãŠã€ã«ã¹ããã³mRNAã¯ã¯ãã³ã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªãè «çæå¶ãæ ãéèŠãªã¿ã³ãã¯è³ªãé»å®³ããçã®çºççãé«ããå¯èœæ§ãããããšã瀺ããŠããã
ãã®ç 究ã¯ãSARS-CoV-2ã¹ãã€ã¯S2ãµããŠããããç现èã«ãããp53ã«ããp21(WAF1)ãTRAILãã¹ã¬ã»ãã¿ãŒDR5ãããã³MDM2ã¿ã³ãã¯è³ªã®æŽ»æ§åãæå¶ããããšããã¿ã€ãã«ã§ããã©ãŠã³å€§åŠã®ç 究è ã«ãã£ãŠèãããã圌ãã¯ãã¯ã¯ãã³ããã³ãŠã€ã«ã¹ã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªã®S2æåããDNAæå·ã®å¿çããã³ä¿®åŸ©ã«ãããŠéèŠãªåœ¹å²ãæããè «çæå¶ã¿ã³ãã¯è³ªã§ããP53ãšçžäºäœçšãããã©ããã調æ»ããã
圌ãã¯ãS2æåãP53ãæå¶ããããšãçºèŠããããã¯ãSARS-CoV-2ææãè «ç圢æãè «çé²è¡ããããŠååŠçæ³æåæ§ã«åœ±é¿ãäžããå¯èœæ§ãããååæ©æ§ãæäŸããããšè¿°ã¹ãŠããã
ãã®ãã¬ããªã³ãã¯ãç 究è ãã¡ãCOVID-19ã¯ã¯ãã³ãSARS-CoV-2ãŠã€ã«ã¹ã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªããçïŒããïŒã®ãªã¹ã¯ãå¢å ãããå¯èœæ§ããããšããæžå¿µã瀺åããŠããŸãã以äžèŠçŽã§ãã
SARS-CoV-2ãŠã€ã«ã¹ã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªã®äžéšã§ããS2ãµããŠãããããè «çæå¶ã¿ã³ãã¯è³ªã§ããP53ã®æ©èœãæå¶ããå¯èœæ§ãããããšã瀺åããŠãããP53ã¯ãDNAæå·ã®ä¿®åŸ©ã现èåšæã®å¶åŸ¡ãè¡ãéèŠãªã¿ã³ãã¯è³ªã§ãããè «çã®çºçãé²ã圹å²ãæ ã£ãŠããã
2.ã¯ã¯ãã³ãšã®é¢é£æ§
ãã®ç 究ã¯äž»ã«ãŠã€ã«ã¹ã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªã«çŠç¹ãåœãŠãŠããããåãã¹ãã€ã¯ã¿ã³ãã¯è³ªãmRNAã¯ã¯ãã³ã«ãã£ãŠäœå ã§çæããããããmRNAã¯ã¯ãã³ãåæ§ã®åœ±é¿ãäžããå¯èœæ§ããããããã«ãããè «çã®åœ¢æãé²è¡ããããŠçæ²»çã«å¯Ÿããæåæ§ã«åœ±é¿ãäžããå¯èœæ§ããããšããŠããŸãã
3.å è¡ç 究ãšã®äžèŽ
å¥ã®ç 究ã§ã¯ãCOVID-19 mRNAã¯ã¯ãã³ã«äœ¿çšããã修食ãããRNAïŒN1-ã¡ãã«ã·ã¥ãŒããŠãªãžã³ïŒããçã®æé·ãä¿é²ããå¯èœæ§ããããšè¿°ã¹ãŠããã